Circulating Dickkopf-1 in hypoxic ischemic neonates

Area of Science:

• Neonatal Medicine
• Biochemistry
• Neurology

Background:

• Hypoxic ischemic encephalopathy (HIE) is a major cause of neonatal brain injury.
• Biomarkers are crucial for diagnosing and assessing the severity of HIE.
• Dickkopf-1 (Dkk-1) is a protein involved in Wnt signaling, with potential roles in brain development and injury.

Purpose of the Study:

• To investigate serum Dkk-1 levels in neonates diagnosed with HIE.
• To compare Dkk-1 levels between HIE neonates and healthy controls.
• To explore the correlation between Dkk-1 levels and HIE severity.

Main Methods:

• Serum Dkk-1 levels were quantified using ELISA.
• The study included 20 neonates with HIE and 20 healthy controls.
• Measurements were performed within 24 hours of HIE symptom onset.

Main Results:

• Serum Dkk-1 levels were significantly elevated in neonates with HIE compared to controls.
• Elevated Dkk-1 levels were observed in HIE neonates experiencing convulsions, receiving multiple anticonvulsant drugs, or showing cranial ultrasound abnormalities.
• A significant increase in serum Dkk-1 levels was noted in neonates with severe HIE.

Conclusions:

• This study demonstrates, for the first time, the release of Dkk-1 into the circulation of neonates with HIE.
• Circulating Dkk-1 levels are higher in neonates with more severe HIE.
• Dkk-1 may serve as a potential biomarker for HIE severity in neonates.